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ABSTRACT 
 
Elizabeth A. Proctor: Inhibiting the formation of ALS-relevant SOD1 oligomers 
(Under the direction of Nikolay V. Dokholyan) 
 
Amyotrophic Lateral Sclerosis (ALS) is an invariably fatal neurodegenerative disease 
selectively affecting motor neurons. The aggregation of Cu, Zn superoxide dismutase (SOD1) 
has been linked to the disease, but the toxic species and mechanism of disease progression 
remain unknown. In this work, we explore two strategies for interfering in SOD1 aggregation: 
preventing the dissociation of the native homodimer, and preventing the association of misfolded 
SOD1 monomers into potentially toxic oligomers. In the first strategy, we elucidate the 
mechanism by which a commonly found post-translational modification, glutathionylation, 
increases the dissociation of native SOD1. We find that the addition of glutathione moieties at 
their modification site near the dimer interface creates steric clashing that causes the two 
monomers to twist in relation to one another, changing the shape and size of the dimer interface. 
These changes to the dimer interface cause a decoupling of dimerization and monomer folding 
processes, which in turn stabilizes a folding intermediate on the path to dimer dissociation, 
increasing the population of SOD1 monomer as observed in experiments. To pursue our second 
strategy, we develop a method to model the structure of meta-stable protein aggregation 
intermediates, which have been implicated as toxic species in ALS. We incorporate experimental 
data from limited proteolysis with computational techniques to obtain the first-ever structural 
model of a meta-stable protein oligomer, a SOD1 trimer isolated in our laboratory that is 
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recognized by conformational antibodies shown to bind disease-relevant misfolded SOD1 
species. We use our structure to design mutations that will stabilize or destabilize the formation 
of SOD1 trimer in vitro, and demonstrate using time-resolved analytical size exclusion 
chromatography that the majority of our designed mutants exhibit the aggregation behavior that 
we predict. 
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This work is dedicated to my uncle, Dr. John H. Johnson, who succumbed to ALS in the summer 
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never stop searching for answers. 
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CHAPTER 1 
INTRODUCTION 
 
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that 
selectively affects motor neurons, resulting in the eventual complete paralysis of patients. ALS 
is invariably fatal, with death occurring in most cases between two to five years following 
diagnosis. In the vast majority of cases, ALS does not affect cognitive, sensory, or autonomic 
processes, and so patients are fully cognizant of their decline. The most common cause of death 
is asphyxiation when paralysis reaches the diaphragm. Approximately 1 in 800 people will 
contract ALS in their lifetime, a number that grows larger as life expectancies increase1–4. 
No cure or even effective treatment currently exists for ALS. The one FDA-approved 
medication available, riluzole, prolongs life by only a few months, mainly in patients who 
experience difficulty swallowing (National Institute of Neurological Disorders and Stroke, 
http://www.ninds.nih.gov/disorders/amyotrophiclateralsclerosis/ALS.htm). Patients often elect 
to stop treatment because they feel that the side effects of riluzole (nausea and fatigue) decrease 
quality of life to an extent that exceeds any therapeutic benefits. Other treatments are palliative 
only: for example, drugs to reduce fatigue, pain, and depression. 
The main deterrent to the development of effective therapeutic strategies for ALS is that 
the underlying cause and molecular mechanism of ALS is unknown5. ALS is generally 
considered to be a collection of diseases, rather than a single disease, with the majority of ALS 
cases (~82%) having no apparent heritability6.  Of the ALS cases known to be genetically linked, 
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~20% are associated with mutations to the homodimeric metalloprotein Cu, Zn superoxide 
dismutase (SOD1)4. The discovery in 19937,8 that mutations to the gene sod1 are linked to ALS 
was the first breakthrough in the search for a molecular mechanism of ALS etiology. Although 
SOD1 mutations account for only a small percentage of total ALS cases, symptoms and 
presentation of SOD1-linked, sporadic, or non-SOD1-linked genetic cases are clinically 
indistinguishable, and require a genetic test to differentiate1,9,10. These similarities motivate the 
general acceptance in the field that similar mechanisms underlie disease etiology in all cases of 
ALS, and that the study of ALS-linked SOD1 mutants will lead to understanding relevant to the 
treatment of all ALS sub-types1,4,9,10. 
Since the initial linking of SOD1 mutations to ALS, over 140 mutations to SOD1 have 
been discovered to confer the disease (ALSOD database, http://alsod.iop.kcl.ac.uk). The vast 
majority of these mutations are destabilizing to either the individual monomers or to the 
monomer-monomer interface, with many of the remaining mutations destabilizing the apo-
monomer11–15. Inclusion bodies containing SOD1 have been found in the motor neurons of both 
familial and sporadic ALS patients16–19. For these reasons, ALS is believed to be a protein 
misfolding disease1. The first step of SOD1 aggregation in ALS is the dissociation of the 
dimeric structure into two metal-bound monomers20,21 (Figure 1). The loss of the dimer 
interface allows the SOD1 monomers to more easily lose their bound zinc and copper ions, 
resulting in unstable apo-monomers that quickly form aggregates. SOD1 aggregates to form 
both small, soluble oligomers and insoluble amyloid fibrils. Whether these various aggregate 
forms lie along the same or competing aggregation pathways remains an outstanding question in 
the field. 
Although misfolding and aggregation results in a loss of the dismutase activity of SOD1,  
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Figure 1. Proposed SOD1 aggregation pathway. “D” native, metallated dimer; “M” native, metallated monomer; 
“M’” misfolded apo-monomer; “O” small, soluble oligomers; “F” large, insoluble aggregates, protofibrils, and 
fibrils. 
this loss of function is not the underlying cause of ALS4. SOD1 knockout mice do not develop 
the disease22, nor does supplementation of wild type SOD1 to mice expressing ALS-relevant 
mutant SOD1 prevent or impede disease onset or progression, nor prolong life expectancy1. 
Therefore, it is thought that SOD1 undergoes a gain-of-function upon mutation, likely related to 
the resulting misfolding and aggregation. However, despite decades of research, the toxic 
species of SOD1 is still unknown, although several candidates have been suggested: insoluble 
fibrils, soluble oligomers, and misfolded monomers16–18,23–34. No toxic candidate species has 
been definitively ruled out to date, but several studies in ALS and other neurodegenerative 
diseases have supported the hypothesis that amyloid fibrils are inert and even possibly 
protective4,35–38, while small, soluble species are present from birth and selectively enriched in 
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motor neurons, having a cytotoxic effect as cells age and can no longer counter their aberrant 
interactions4,25,39,40. For example, ALS-relevant mutant SOD1 has been shown to interfere with 
conductance across the mitochondrial membrane41 and cause structural damage to the 
mitochondria42, as well as induce ER stress and activate cell death pathways43, among other 
deleterious effects4. However, despite these advances in identifying toxic interactions of 
misfolded SOD1 in the cell, the identity of the SOD1 species involved could not be verified, 
although in each case the toxic SOD1 species was known to be small and soluble. 
Aggregation and the formation of non-native species of SOD1 are intimately implicated 
in both genetic and sporadic forms of ALS, but little is known about the structure or toxicity of 
the various non-native toxic candidates. In this work, we incorporate experimental data to guide 
computational modeling of non-native SOD1 species. We use our models to deduce 
mechanisms of misfolding and aggregation and to develop strategies to inhibit the formation of 
non-native SOD1 oligomers. The scientific advances we describe contribute toward knowledge 
of the molecular etiology of ALS and provide possible avenues for the development of 
therapeutics.  
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CHAPTER 2 
MECHANISM OF DIMERIC SOD1 DESTABILIZATION BY GLUTATHIONYLATION 
 
SOD1 is ordinarily a highly stable protein, with a folding free energy difference (ΔG) of 
25 kcal/mol20,44–46. For comparison, a typical globular protein features a ΔG of 5 to 15 
kcal/mol47. Although disease-linked mutations are usually destabilizing (as described above), 
these mutations only subtract, on average, 5 kcal/mol from the stability. This destabilization 
brings the free energy of folding to 20 kcal/mol, still significantly more stable than the typical 
globular protein, which leaves us with the question: how can this super-stable protein misfold in 
ALS? 
 The environment can play a large role in influencing cellular conditions. Oxidizing 
conditions, such as those induced by exercise, pollution, or harmful chemicals, have been shown 
to promote the misfolding of proteins, including SOD148. Oxidized forms of SOD1 feature 
reduced stability, and have been implicated in ALS48. Wilcox and colleagues found that SOD1 
modified by the addition of at least one glutathione moiety, an antioxidant compound that 
normally protects cysteine residues from oxidation, significantly destabilizes the dimeric form 
of SOD1 and promotes dissociation into monomers49. Moreover, they found that 50% of SOD1 
is glutathionylated in human blood. The destabilization of SOD1 dimer caused by this common 
post-translational modification could explain not only the misfolding of marginally destabilized 
ALS-linked mutant SOD1, but also the misfolding and aggregation of wild type SOD1 seen in 
sporadic cases of ALS50. This hypothesis is especially compelling given the increased 
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occurrence of sporadic ALS in groups of individuals exposed to oxidizing chemicals: Italian 
soccer players exposed to fertilizers on the field51,52, veterans of the Gulf War exposed to 
chemical warfare agents53,54, and natives of Guam55,56 and Japan57 exposed to local toxins, 
among others4. How glutathione, itself an antioxidant, modifies an antioxidant protein to result 
in protein dissociation and enhanced aggregation remains unknown. To address this question, 
we computationally model glutathionylated wild type and mutant SOD1 and perform discrete 
molecular dynamics (DMD) simulations in order to determine the thermodynamic and structural 
effects of glutathionylation. 
 
2.1 Modeling and simulation of glutathionylated SOD1 
 Modeling. We obtain structures of post-translationally modified mutant and wild type 
SOD1 using the known X-ray crystallographic structure of wild type SOD1 (PDBID 1SPD) as a 
reference structure. We constrain glutathione molecules to be covalently (permanently) bound 
to cysteine-111, and the zinc and copper ions to be permanently bound to their ligand residues. 
We obtain parameters for bond length, angle, and dihedral constraints for glutathione, metals, 
and disulfide bonds from the CHARMM19 force field58. All dimers are homo-modified. We 
then mutate the wild type structure to generate each disease-relevant mutant (A4V, G37R, 
G93A, H46R, and I112T) using the Eris suite59,60. We do not make structural adjustments to 
those residues participating in metal-binding, glutathionylation, or disulfide bond interactions 
unless they are necessary to the system of interest, as in the case of the H46R mutation, which 
coordinates the catalytic copper ion. 
In order to minimize steric clashes between modifications and the SOD1 protein and to 
relax the SOD1 backbone, we iteratively relax and equilibrate each system utilizing all-atom 
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DMD. We perform three simulation iterations, each with a progressively lower heat exchange 
rate (0.2, 0.02, and 0.002 fs–1, respectively). Each iteration has a duration of 50 ps at a reduced 
unit temperature of 0.5 kcal/(mol!kB) (∼ 251 K). 
 Simulation. The discrete molecular dynamics (DMD) simulation engine is a variation on 
traditional molecular dynamics engines, where pairwise interactions between particles are 
modeled using step functions in place of continuous potentials. The DMD algorithm is 
discussed in detail elsewhere61,62. We utilize the all-atom protein model62,63, in which all heavy 
atoms as well as polar hydrogens are explicitly represented. Bonded interactions are described 
by infinite square well constraints on bond lengths, angles, and dihedrals, making bonded 
interactions effectively permanent. Non-bonded interactions are discretized from the Medusa 
force field64, which includes van der Waals interactions (Lennard-Jones potential), solvation 
(Lazaridis-Karplus model65), and explicit hydrogen bonding (reaction algorithm66).  
We utilize the replica exchange (REX) method to perform simulations of multiple copies 
of the same system in parallel at various temperatures67,68. The REX method is explained in 
detail elsewhere67,68, and is useful for exploring dynamics and thermodynamics of folding and 
unfolding. Briefly, at given time intervals, replicas of neighboring temperatures exchange 
temperature values according to a Metropolis-based stochastic algorithm. This exchange allows 
the system to overcome energetic barriers at higher temperatures, while retaining a realistic free 
energy profile at lower temperatures. We set the temperature exchange interval at 1000 DMD 
time steps (approximately 50 ps). We choose the temperature range of the replicas to cover the 
entire transition profile of the system, such that the system is disordered at the highest 
temperatures and stable and ordered at the lowest temperatures. In order to find the ideal range 
and separation between replicas, first we perform a wide range of single-temperature 
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simulations and construct a Temperature vs. Energy plot, from which the transition profile of 
the system is apparent. We then choose temperatures for replicas that cover this range, and fine-
tune such that the successful exchange rate between adjoining replicas is between 0.2 and 0.7. 
In the monomer species, we perform 12 replica simulations with length of 100 ns at 
temperatures of 0.50 (∼252 K), 0.52 (∼262 K), 0.54 (∼272 K), 0.56 (∼282 K), 0.58 (∼ 292 K), 
0.60 (∼ 302 K), 0.62 (∼ 312 K), 0.64 (∼ 322 K), 0.66 (∼ 332 K), 0.68 (∼ 343 K), 0.70 (∼ 353 K) 
and 0.72 (∼ 363 K) kcal/(mol!kB). In the dimer species, we perform 16 replica simulations with 
length of 50 ns at temperatures of 0.48 (∼ 242 K), 0.495 (∼ 249 K), 0.51 (∼ 257 K), 0.525 (∼ 
264 K), 0.54 (∼ 272 K), 0.555 (∼ 280 K), 0.57 (∼ 287 K), 0.585 (∼ 295 K), 0.60 (∼ 302 K), 
0.615 (∼ 310 K), 0.63 (∼ 317 K), 0.645 (∼ 325 K), 0.65 (∼ 327 K), 0.67 (∼ 337 K), 0.69 (∼ 347 
K) and 0.71 (∼357 K) kcal/(mol!kB). We note that temperatures used in MD simulations, 
including DMD simulations, often do not equate directly with physical temperatures. For 
example, the melting temperature of wild type SOD1 dimer that we calculate here differs from 
the experimentally-measured value of 93°C (366 K)69. However, simulations accurately reflect 
the relative changes in melting temperature, which are relevant to our studies. 
To test for sufficient sampling, we split our simulation trajectories in half and compare 
the distribution of energies for the two halves. We obtain similar results for both halves, and 
therefore conclude that sampling is sufficient to reach equilibrium. 
 
2.2 Steric clashing of glutathione in the interface causes relative rotation of SOD1 
monomers  
The site of glutathionylation on SOD1 is cysteine-11149, which is located at the dimer 
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interface. We note in single-temperature simulations that glutathionylated SOD1 features a 
distinct change in the orientation of the two monomers with respect to one another. To quantify 
this change, we represent the two monomers of SOD1 as cylinders that, instead of being 
oriented in a parallel fashion, are positioned at a torsional angle to one another (Figure 2). We 
then measure the angle between the axes of these cylinders. 
 We define the radial axis vector for each monomer by creating vectors along each beta-
strand making up the approximately cylindrical beta-barrel, and averaging over the components. 
We define all beta-strand vectors to have the same directionality sign, and we length-normalize 
the vectors before averaging. The representative vector therefore features the three-dimensional 
average direction of all beta-strand vectors in each monomer. In order for these calculations to 
be meaningful, structures must be both folded and associated. In order to eliminate structures 
with monomer unfolding, we calculate the aligned RMSD (Kabsch RMSD70, KRMSD) between 
the beta-barrel alpha carbons of each monomer of the initial wild type-like structure and those 
of the corresponding monomer of each simulation snapshot (snapshots recorded every 5 ps). We 
impose a KRMSD cutoff of 4 Å, which we choose on the basis of the distribution of KRMSD 
values from all snapshots of all simulated species. To eliminate dissociated structures, we 
measure the distance between the centers of mass of the two monomers, which we calculate on 
the basis of the alpha carbons in the beta-barrels. We impose a cutoff of 35 Å, which we choose 
in the same manner as the cutoff for KRMSD. We retain those structures of each species that 
meet the criteria for both folded and associated, and measure the angle between the vectors 
characterizing the two monomers. We calculate the angle between the two vectors v1 and v2 as: 
 
This torsional angle is affected by glutathionylation, likely because the bulkiness of the 
θ = arccos v1 ⋅ v2a b
"
#
$$
%
&
''
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glutathione moieties in the dimer interface causes steric clashing that forces the two monomers 
to rotate in opposite directions to accommodate the modifications. However, the effect of this 
steric clash differs in different SOD1 mutants (Figure 2, Table 1). These differences are 
potentially due to variation between the mutants in their dimer interface configuration and how 
they are affected by the addition of glutathione (Figure 3). 
 
2.3 Relative rotation of SOD1 monomers causes changes in dimer interface composition 
The change in the relative orientation of the SOD1 monomers within the dimer 
necessarily changes which residues are in contact, as well as the dimer interface area. In order to 
determine the extent of the change in dimer interface contacts, we construct contact maps for 
the dimer interface residues, and compare contact maps from unmodified structures with those 
of the glutathionylated structures. 
 We define two residues as being in contact in the dimer interface if the two alpha 
carbons are within 10 Å of each other. At each simulation snapshot, we evaluate contacts 
between the two monomeric chains. We normalize the count between every pair of residues for 
the total number of simulation snapshots. 
We find that the relative rotation of the monomers affects the dimer interfaces of the 
wild type and various mutant SOD1s differently. We observe three different types of changes: 
(type 1) overall loss of dimer interface contacts and area, (type 2) overall gain of dimer interface 
contacts and area, and (type 3) a shift of the dimer interface while maintaining interface area. 
For example, in wild type, A4V, and H46R-SOD1, we observe a loss of interactions in the 
dimer interface of the glutathionylated species (type 1) (Figure 3), while in G93A-SOD1, we 
observe an overall increase in interface contacts upon modification, implying that the 
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Figure 2. Structural effects of glutathionylation on the angle between monomers in SOD1 dimer. (a) 
Depiction of the angle, θ, measured between monomers in the SOD1 dimer. Distribution of angle between 
monomers in constant temperature populations of modified and unmodified wild type and mutant SOD1 (b-g). The 
legend shown for (b) and (c) is relevant also for (d-g). 
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Table 1. Torsional angle between monomers within SOD1 dimer. Peak values of the distributions of the angle 
between monomers observed in Figure 2. 
 Angle between monomers (°) 
Wild-type Unmodified 60 
Glutathionylated 40 
A4V Unmodified 45 
Glutathionylated 50 
G37R Unmodified 46 
Glutathionylated 50 
G93A Unmodified 53 
Glutathionylated 51 
H46R Unmodified 47 
Glutathionylated 50 
I112T Unmodified 55 
Glutathionylated 50 
 
 
 
Figure 3. Effects of glutathionylation on SOD1 dimer interface interactions. Difference maps of the frequency 
of interactions between residues on each monomer with residues on the opposing monomer over the course of low 
temperature simulations. Red denotes a gain in contact frequency between given residues upon glutathionylation, 
while blue denotes a loss. Monomer-monomer interactions are not necessarily symmetrical. 
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introduction of glutathione induces the formation of non-native interactions in the interface 
(type 2) (Figure 3). In contrast, in I112T-SOD1, losses of interface contacts are accompanied by 
a gain in the residues directly adjacent (type 3) (Figure 3), which implies a shift in the location 
of the dimer interface and, therefore, a shift in its makeup. We find a similar shifting of contacts 
in the C-termini of G37R-SOD1, implying structural movement in that area (Figure 3). 
Taken together, these results imply a shift in the residue composition and position of the 
dimer interface upon glutathionylation, likely due to the change in orientation of the two 
monomers forced by the presence of bulky glutathione moieties in the dimer interface. A change 
in the identity, and in some cases the number, of dimer interface contacts can result in the loss 
of monomer-monomer binding affinity and increased dimer dissociation. In a parallel 
experimental study50, we find a shift toward the monomer population in wild type and mutant 
A4V SOD1 (group 1), but an increase in the rate of monomer formation in mutant I112T-SOD1 
(group 3), which suggests that the contact loss observed in glutathionylated wild type and A4V-
SOD1 (Figure 3) results in a loss of monomer-monomer binding affinity, whereas the overall 
shift in contacts seen in I112T-GSH (Figure 3) instead affects kinetics, resulting in an increased 
koff for the dissociation reaction50. 
In addition to shifting the dimer interface, glutathionylation appears to introduce an 
asymmetry in monomer-monomer interactions in wild type SOD1. For example, we observe 
that interactions near residues 60A-115B (A and B represent the two monomers) disappear in 
glutathionylated wild type SOD1 when compared to the unmodified protein, but the residue 
115A-60B interactions remain (Figure 3). Also, in some residues one monomer may exhibit 
only a shift in interface contacts, losing interaction frequency in one residue but gaining it in an 
adjacent residue, while the other monomer loses contacts with no compensating gain. This 
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compromise may introduce strain into the structure that contributes to the increased dissociation 
observed experimentally49,50.  
We also note that the majority of SOD1 residues that interact with the glutathione 
moieties are located in the small loop segments connecting beta-strands (Figure 4). Interactions 
with glutathione thus may interrupt the side-chain alignment necessary for formation of the 
beta-barrels, which would result in the loss of crucial contacts and therefore dissociation. 
 
Figure 4. SOD1 residues interacting with glutathione modification. Glutathione, copper, and zinc are shown in 
sphere representation. Residues with the highest frequency of interaction with glutathione are colored teal. 
2.4 Changes in SOD1 dimer interface upon glutathionylation lead to destabilization and 
decoupling of dimer dissociation and monomer unfolding 
In order to assess how changes in the dimer interface affect the folding thermodynamics 
of SOD1, we calculate the density of states by combining multiple trajectories from REX DMD 
simulations using the MMTSB tool71 for the weighted histogram analysis method (WHAM). 
WHAM computes the density of states by combining histograms from over-lapping simulation 
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trajectories. Given the density of states ρ(E), the folding specific heat at constant volume, CV, is 
computed at various temperatures according to the partition function: 
 
where E is the potential energy, T is the temperature, and kB is the Boltzmann constant. Because 
we do not observe multiple unfolding and refolding transitions in our simulations, we do not 
expect to obtain fully quantitative free energy landscapes for the various species of SOD1. 
However, we expect to gain insight into the stability of both the monomer and dimer species by 
using the unfolding transition temperature, which corresponds to the major peak in specific heat 
(Figure 5 )72. Specific heat is a measure of the amount of energy necessary to increase the 
temperature (kinetic energy) of the protein. Hence, a peak in specific heat corresponds to a 
transition between energetic states, where energy is devoted to raising the potential as opposed 
to the kinetic energy of the complex. Monomer species exhibit one significant thermodynamic 
transition, corresponding to monomer unfolding (Figure 5). Dimer species also exhibit one 
major transition, with the transition temperature shifted significantly to higher temperature as 
compared to the corresponding monomer species. Because the SOD1 dimer species feature one 
major peak rather than two peaks, corresponding to dimer dissociation and monomer unfolding, 
we conclude that dimer dissociation and monomer unfolding are highly coupled processes. The 
strong interactions in the dimer interface stabilize the individual monomers by shifting the 
unfolding transition to a higher temperature, keeping the dimer associated and folded at 
temperatures higher than the monomer unfolding temperature. 
We observe that, in wild type and all mutant variants except A4V and I112T, 
glutathionylation causes a decrease in the coupled nature of the dissociation/unfolding transition. 
All unmodified species exhibit a single peak in specific heat, representing a single transition,  
Z = dEρ(E)exp(−E / kBT )∫
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Figure 5. Thermodynamics of SOD1 unfolding in glutathionylated and unmodified species. Potential energy 
and specific heat of dimer and monomer species for wild type and mutant glutathionylated and unmodified SOD1. 
Monomer data is represented by grey curves in in energy vs. temperature plots, dimer is represented by black. 
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but glutathionylated species feature a shoulder, representing a partial decoupling of the two 
processes (Figure 5). 
 We find that glutathionylation destabilizes the dimer by shifting the transition to a lower 
temperature. The exception to this trend is G93A-SOD1, where the glutathionylated species is 
stabilized with respect to the unmodified form (Figure 5, Table 2). 
Table 2. SOD1 dimer transition temperatures. Major transition temperature of the various SOD1 dimer species 
(Figure 5). 
 Transition Temperature (K) 
Wild type Unmodified 340 
Glutationylated 339 
A4V Unmodified 338 
Glutathionylated 331 
G37R Unmodified 341 
Glutathionylated 338 
G93A Unmodified 329 
Glutathionylated 329 
H46R Unmodified 339 
Glutathionylated 341 
I112T Unmodified 339 
Glutathionylated 340 
 
We observe in dimer species that the maximum value of the major peak in specific heat 
(corresponding to the energy input needed to raise the temperature of the complex by 1 °C 
during the dimer dissociation/unfolding transition) is highest in the unmodified species, as 
opposed to in the glutathionylated species (Figure 5), with the exceptions of G93A and I112T. 
The absolute value of the specific heat indicates the cooperativity of the phase transition. 
Therefore, this observation suggests that the dissociation/unfolding transitions are more 
cooperative in the unmodified species, and that glutathionylated species exhibit a more gradual 
melting transition from associated to dissociated states. 
In agreement with experimental studies50, we find that modification does not 
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significantly affect monomer stability (Figure 5). All of these effects taken together imply that 
the destabilization of SOD1 dimer found experimentally is due to disruption of the coupling of 
dimerization and monomer folding. Interactions across the dimer interface strengthen the 
stability of the SOD1 monomers, but these interactions are disrupted by the twisting of the 
monomers in relation to each other, induced by the steric effects of bulky glutathione molecules 
near the dimer interface. The uncoupling decreases the stability of dimerization, increasing 
dimer dissociation. 
 
2.5 Glutathionylation stabilizes an intermediate folding state in SOD1 
In order to study the more subtle transitions between native-like states that may further 
explain an increased dissociation in glutathionylated species, we examine the potential energy 
distributions of structures in the mid-range temperature region, 275–325 K, just reaching the 
lower bound of the dissociation/unfolding transition (Figure 6). These structures should include 
populations of native-like, dissociated, and any intermediate states. All energies discussed are 
potential energies of the system; contributions from internal potential energy of the modification 
molecules are minimal in comparison to the potential energy of the system, and therefore no 
adjustment is needed for comparisons of potential energy between modified and unmodified 
systems.  
In each system, we observe the existence of at least three low-energy states with 
Gaussian-like peaks or shoulders in the energy distribution. We fit each energy distribution with 
a trimodal Gaussian, corresponding to the three lowest energy peaks and/or shoulders in the 
distribution, and identify the energy of each state as the mean of its respective Gaussian 
function. Because the individual Gaussian functions corresponding to each state overlap 
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Figure 6. Deciphering SOD1 energetic states in glutathionylated and unmodified species. Distributions of total 
potential energy throughout simulations, sampled at T=0.55-0.65 kcal/(mol!kB), with representative structures for 
each of the three low-energy states. 
significantly, and deconvolution with respect to individual structures is not possible, we identify 
representative structures by clustering structures whose energies fall within 1 kcal/mol around 
the mean of the respective Gaussian by RMSD using the OC suite73. Structures with energies in 
this range have a higher probability of belonging to the energetic state of interest than of being a 
member of the tail of one of the other states. We choose RMSD cutoffs for clustering as the 
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global maximum in a histogram of pairwise RMSDs of all structures clustered. We choose the 
centroid of the largest cluster as the representative structure for each state. The largest cluster is 
in all cases at least four times the weight of the next-largest cluster. 
The three delineated low-energy populations correspond to the native state and the early 
excitation states in the dissociation/unfolding process. The first state is a low-energy state with a 
native-like structure; the second state has undergone a conformational change that can be 
characterized as a “loosening” of the beta-barrels and/or a slight movement outward of the two 
centers of mass (Figure 6, Figure 7, Table 3); and the third state is the dissociated state, with 
partial unfolding due to the coupled nature of the dissociation and unfolding processes.  
The amount of differentiation between the states in partial unfolding or separation of the 
monomers varies between mutants. Although in some glutathionylated species, namely A4V, 
G37R, and I112T, the representative structure of the intermediate energetic state is dissociated 
(Figure 6), we observe from the distributions of monomer separation and monomer unfolding 
that, statistically, the intermediate state as a whole is still distinct from the dissociated state 
(Figure 7, Table 3). In G93A, the unmodified species features an intermediate state that 
maintains very few dimer interface contacts and, therefore, has a greater tendency to be 
dissociated than the intermediate states of other mutant variants. However, glutathionylation 
restores the intermediate state to a form with similar characteristics to the other mutants.  
In general, we find that glutathionylation does not destabilize the native state; in most 
mutant variants, the native-like state, which occurs at approximately –550 kcal/mol, does not 
undergo a significant energetic change upon glutathionylation (Figure 6, Table 4). However, the 
intermediate state population is shifted to a lower energy in glutathionylated species, decreasing 
the potential energy gap between the native-like and the dissociated states and increasing the 
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probability of the protein to misfold and dissociate. In many of the glutathionylated species, the 
third (dissociated) state is also stabilized as compared to in the unmodified species, and the  
 
 
Figure 7. Structural characterization of glutathionylated and unmodified SOD1 energetic populations. 
Distributions of values for the monomer aligned KRMSD from the starting structure, used as a measure of β-barrel 
integrity and unfolding, and the distance between monomer centers of mass, used as a measure of dimer 
dissociation. We show distributions for unmodified and glutathionylated wild type and mutant SOD1 for the first, 
second, and third energy populations described in Figure 10. The legend shown is relevant for all panels. 
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Table 3. Structural characterization of glutathionylated and unmodified SOD1 energetic populations. 
Distribution averages for the monomer aligned RMSD from original structure, a measure of β-barrel integrity, and 
distance between monomer centers of mass, a measure of dissociation. Values shown in each cell are for the first, 
second, and third energy populations described in Figure 6. The full distributions of the properties below are shown 
in Figure 6. 
 Monomer RMSD (Å) COM-COM distance (Å) 
1 2 3 1 2 3 
Wild 
type 
Unmodified 1.75 3.40 4.64 33.89 56.46 66.11 
Glutathionylated 2.67 3.60 4.26 45.57 65.43 71.84 
A4V Unmodified 2.47 3.32 4.12 27.55 43.94 57.86 
Glutathionylated 1.98 3.75 6.71 29.31 47.37 59.16 
G37R Unmodified 2.77 3.92 6.05 32.56 34.88 49.444 
Glutathionylated 2.19 4.20 4.24 26.67 66.09 72.34 
G93A Unmodified 1.85 4.28 5.68 31.23 72.26 76.76 
Glutathionylated 2.27 3.06 4.16 42.12 58.86 66.71 
H46R Unmodified 1.61 3.47 7.38 26.29 41.01 51.75 
Glutathionylated 2.39 2.73 4.27 34.66 32.35 54.96 
I112T Unmodified 2.35 2.99 5.09 29.23 45.35 67.88 
Glutathionylated 2.44 3.28 5.99 34.57 58.86 76.44 
 
Table 4. Energetic populations of glutathionylated and unmodified SOD1. Peak values of the energetic 
populations observed in Figure 6, and the resulting energy differences between the states. 
 Peak energy of population 
(kcal/mol) 
Energy difference between 
states (kcal/mol) 
1 2 3 ΔE1"2 ΔE2"3 ΔE1"3 
Wild 
type 
Unmodified -567 -433 -340 134 93 227 
Glutathionylated -562 -497 -414 65 83 148 
A4V Unmodified -566 -439 -382 127 57 184 
Glutathionylated -569 -449 -321 120 128 248 
G37R Unmodified -553 -449 -304 104 145 249 
Glutathionylated -576 -474 -387 102 87 189 
G93A Unmodified -556 -419 -309 137 110 247 
Glutathionylated -559 -496 -420 63 76 139 
H46R Unmodified -530 -426 -279 104 147 251 
Glutathionylated -512 -448 -339 64 109 173 
I112T Unmodified -539 -461 -325 78 136 214 
Glutathionylated -545 -473 -306 72 167 239 
 
 
overall ΔE between the native-like and the dissociated populations is decreased (Figure 6, Table 
4). 
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2.6 Possible implications of post-translational modifications of SOD1 in ALS 
 A strong coupling of the dimer dissociation and monomer unfolding processes has 
important implications for SOD1 overall protein stability and aggregation. Dimerization 
significantly stabilizes the folded monomer, which implies that contacts in the dimer interface 
contribute to the integrity of the monomer beta-barrels. As these contacts are broken, the intra-
monomer interactions maintaining the beta-barrel formation of each monomer are also broken, 
causing simultaneous dissociation and partial unfolding. The unfolding process is then more 
favorable to complete upon full dissociation. 
Supporting this hypothesis, both wild type and mutant unmodified species in general 
dissociate and unfold more sharply than the glutathionylated forms with an increase in 
temperature (Figure 5). This finding implies that the shifting or gain of non-native contacts 
(Figure 3) that occurs in glutathionylated species causes a loss of cooperativity in the interface 
and intra-monomer interactions. This loss of cooperativity allows some contacts to be lost much 
more frequently than others, whether due to a structural change or the steric interference of the 
modification molecules. A loss in interaction cooperativity may be manifest in the stabilization 
of the intermediate state, causing a decreased potential energy gap between the native and 
dissociated states (Figure 6, Table 4). Interactions between the glutathione moieties and their 
associated monomer may also be responsible for this more drawn-out dissociation interaction 
and loss of cooperativity; the modification sites are located near the dimer interface (Figure 4), 
and interactions with the monomers could disrupt or weaken native dimer interface interactions. 
This effect could possibly be remedied by the introduction of additional interactions in the form 
of a drug that would bind, bridging the dimer interface and holding it together, as was found by 
Ray et al.74. In addition, a drug could be designed that would interfere with the modification of 
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SOD1 in the first place, whether by occupation or blocking of the modification site or inhibition 
of the modification binding interaction. 
Here we study homo-modified species of wild type and mutant SOD1, but in vivo SOD1 
may exhibit significant hetero-modified populations in addition to homo-modified species. In 
the current experimental characterization of post-translational modifications from erythrocytes 
(mass spectrometry)49,50, dimers are necessarily dissociated before measurement, and so it is 
impossible to determine whether dimers are hetero- or homo-modified in vivo using this method. 
The molecular mechanism of glutathionylation is still unknown, so it is unclear whether 
modification of the individual monomers is a cooperative or an independent process. However, 
we find that the presence of only one glutathione moiety near the dimer interface disrupts or 
changes monomer-monomer contacts and induces many of the same effects that we observe in 
homo-modified species. 
The results above indicate that the post-translational modification of glutathionylation 
affects the energetic and structural properties of wild type and mutant SOD1. The effect varies 
between mutants, suggesting that glutathionylation may have varied effects on the stability of 
the dimer of the various genetic mutations, and for different reasons. For example, the A4V 
dimer appears to be largely stabilized by glutathionylation, while the wild type dimer is 
destabilized by glutathionylation. However, with the exceptions of A4V and I112T, 
glutathionylation of SOD1 has a dramatic effect on decreasing the potential energy gap between 
the native-like state and the dissociated state. We infer from this finding that the presence of 
glutathione, a marker of oxidative stress in the cell75, would be detrimental in most types of 
familial ALS. This finding corroborates with reports that exercise76 and electrical stimulation77 
of ALS model animals results in a more rapid and severe disease progression, because both of 
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these would produce increased oxidative stress in cells and hence increased levels of 
glutathionylated protein78. An environmental factor such as oxidative stress could help to 
explain the differences in disease progression between the various ALS-causative mutants. 
Indeed, recent research shows a strong link between oxidative stress and ALS4, as oxidative 
stress contributes to misfolding and aberrant interactions of SOD1, inflammation, and 
mitochondrial malfunction observed in the disease. Our results indicate that the oxidative 
modification of SOD1 by glutathione could be a contributing factor to the linkage between 
oxidative stress and ALS. 
On a further note, because glutathionylation decreases the potential energy gap between 
the native-like and dissociated states in wild type SOD1, and glutathionylation of SOD1 is 
present even in healthy individuals49, glutathionylation caused by oxidative stress to motor 
neurons could be a factor in sporadic ALS. The late onset of ALS suggests that an 
environmental trigger could exist for both familial and sporadic cases, which fits with the 
increased occurrence of sporadic ALS in athletes52 and soldiers54 as compared to the general 
population; both of these groups experience more extreme and frequent oxidative stress than 
does the average individual. Glutathionylation of SOD1 due to environmental factors could also 
explain incomplete penetrance of some disease-linked SOD1 mutations, and the relatively small 
destabilization (~5 kcal/mol) caused by disease mutations as compared to the high stability of 
SOD1 (25 kcal/mol)4. Such environmental factors could possibly be counteracted with a drug or 
lifestyle decisions. Further investigation into the mechanism of post-translational modification 
in SOD1 could illuminate preventative measures against the observed increased dissociation and 
unfolding, and hence inhibit aggregation and disease. 
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CHAPTER 3 
CONTROLLING THE FORMATION OF SOD1 OLIGOMERS 
 
 The aggregation of SOD1 has been linked to ALS4, but the toxic species that causes 
motor neuron death is still unknown. SOD1 is known to form several diverse species in its path 
to aggregation: misfolded monomers; non-native dimers and other small, soluble oligomers; 
large, insoluble aggregates and proto-fibrils; and stable, SDS-resistant fibrils16–18,23–34. However, 
the road map to SOD1 aggregation remains a mystery: we do not know which species are 
precursors or products of which others, which lie on the same versus competing pathways, and 
which may form completely independently of others. Khare and colleagues have elucidated a 
part of this puzzle by showing that SOD1 aggregation begins with the dissociation of native, 
metallated dimer79. The resulting monomers then lose their copper and zinc ions, destabilizing 
the monomeric structure and allowing the monomer to misfold (Figure 1)79. Khare and 
colleagues found that the formation of large SOD1 aggregates increases in proportion with the 
available population of monomer, demonstrating that SOD1 monomer is the seed for SOD1 
aggregation.  
Two types of SOD1 aggregates have been isolated in diseased cells: large, insoluble 
aggregates, including SDS-stable fibrils; and small, soluble oligomers16–18,23–34. Researchers at 
first thought that the large, stable amyloid-like fibrils were the cause of cell death in ALS, but 
recent evidence demonstrates that large fibrils are mostly inert4. Instead, it is the small, soluble 
oligomers that have been shown to undergo aberrant interactions in the cell4. Soluble, misfolded 
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SOD1 is known to cause endoplasmic reticulum stress43, defective axonal transport80,81, 
mitochondrial malfunction41,42, withdrawal of axon guidance signals82, and both oxidative and 
nitrative stress83,84.  
Because small, soluble oligomers have been shown to activate cell death pathways4,43, 
they are prime candidates for the cytotoxic species responsible for ALS. Recent work has 
demonstrated that promoting the formation of large, insoluble aggregates and fibrils decreases 
the population of small, soluble aggregates and therefore may be a protective pathway in the 
cell4,35–38, but an abundance of large aggregates in the cell poses its own risks and deleterious 
effects. We propose to instead inhibit the formation of the potentially toxic oligomers by 
interfering in the pathway to their formation, directly inhibiting the association of the misfolded 
monomers into toxic oligomers. In order to implement this strategy, we need structural 
knowledge of the toxic oligomers, specifically about the non-native monomer-monomer 
interfaces. Recently, Redler and colleagues have identified a meta-stable, small, soluble 
oligomer of SOD1: an SOD1 trimer (Redler et al., submitted). Using size exclusion 
chromatography, they find that under destabilizing conditions, both wild type and mutant SOD1 
will dissociate to form monomer and reassociate to form trimer over a 24-hour period (Figure 8). 
This trimeric species can be isolated and is then stable at low pH (3.5), a destabilizing 
environment that Khare and colleagues have shown produces accelerated but physiologically 
relevant misfolding and aggregation20. Antibodies developed to recognize disease-causative 
mutant and misfolded SOD185,86 also specifically bind the trimer, but do not bind native dimeric 
or monomeric SOD1, implicating SOD1 trimer as a potential toxic species in ALS (Figure 9) 
(Redler et al., submitted). However, the transient nature of this meta-stable species makes X-ray 
crystallization impossible, and high-resolution NMR is infeasible because of its size 
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Figure 8. Wild type SOD1 forms a stable trimer under destabilizing conditions. Aggregation of metallated 
wild type SOD1 from human erythrocytes under destabilizing conditions (pH 3.5) as measured over 24 hours by 
size exclusion chromatography. The native dimer dissociates into monomer, and then forms a trimer. Plot courtesy 
of Kyle Wilcox and Rachel Redler. 
 (approximately 48 kDa). To address this issue, we design a method that combines low-
resolution experimental data with computational modeling tools in order to obtain structures of 
meta-stable protein aggregation intermediates. 
 
3.1 Method for structural determination of meta-stable protein aggregation intermediates 
 We cannot determine the structure of meta-stable protein aggregates at high resolution 
using traditional experimental methods because of their instability and size. Likewise, with 
three protein chains totaling 459 residues, SOD1 trimer is too large to obtain a structure 
computationally in an ab initio manner. Therefore, we design a method to incorporate any 
structural information that can be obtained experimentally into an energetic function to evolve  
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Figure 9. SOD1 trimer is selectively bound by antibody raised against disease-causative SOD1 species. (Left) 
The conformational antibody C4F685 is shown to bind the ALS-causative mutant G93A-SOD1, as well as oxidized 
SOD1, which has been linked to cytotoxicity, but not wild type SOD1. Importantly, C4F6 does bind to misfolded 
wild type SOD1 present in SOD1 inclusions in tissue from a patient afflicted with sporadic ALS. Image adapted 
from Bosco et al.85 (Right) C4F6 antibody selectively binds to SOD1 trimer at various concentrations, but does not 
bind to native SOD1 dimer, and exhibits minimal binding to SOD1 monomer. Image courtesy of Lanette Fee. 
the native SOD1 structure into a SOD1 trimer model that we verify experimentally. 
 Our method takes advantage of structural information obtained from limited proteolysis 
experiments. Incubation of SOD1 with various proteases provides a diverse range of cleavage 
site data points. Each single-enzyme experiment repetition lasts for only enough time to obtain 
one to two cleavage sites (1-5 minutes, depending on enzyme and pH). Limited proteolysis 
experiments are performed at 25 °C using chymotrypsin (pH 7.8), pepsin (pH 3.5), proteinase K 
(pH 4), and V8 (pH 4) in 100 mM buffer appropriate to pH (pH 3.5: sodium acetate, pH 4: 
phosphate, or pH 7.8: Tris). We then determine the identity of the cleavage sites using mass 
spectrometry, matching the resulting fragment sizes against possible SOD1 peptide fragments 
using the MASCOT database87.  
The structural information gained from limited proteolysis experiments comes from the 
knowledge that protease cleavage sites must by necessity be located in regions of the protein 
that are exposed to the solvent, so that the proteolytic enzyme may access the site. In addition, 
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the 11-12 residues directly surrounding the cleavage site (5-6 residues on each side) must be 
flexible and unstructured in order for the region to conform to fit inside the protease active 
site88,89. Using the knowledge that any cleavage site obtained from experiments will have to be 
both solvent-exposed and unstructured, we can create a quantitative bias for use in discrete 
molecular dynamics (DMD) simulations that will perturb the structure of native SOD1 
monomers to obtain the structure of SOD1 trimer.  
Incorporation of experimental constraints.  To incorporate information from limited 
proteolysis experiments into DMD simulations, we create an algorithm for converting 
knowledge of the sequence positions of proteolytic cleavage sites into pairwise simulation 
constraints (Figure 10). The formation of trimeric SOD1 is made possible by a perturbation to 
the native state, which occurs as local unfolding in a background of native interactions. To 
account for this phenomenon, we first represent the native background as a Gō potential90,91, 
assigning a pairwise attraction of 1 kcal/mol between pairs of residues with Cβ-Cβ distance less 
than 7.5 Å. Next, we define a bias potential based on the location of proteolytic cleavage sites: 
because each cleavage site must necessarily be (i) solvent-exposed and (ii) unstructured, both 
criteria which result in few interactions with other residues, we assign a repulsive interaction of 
energy E0 between the cleavage site j and every other residue in the system. Because residues 
near a solvent-exposed site are also likely to be solvent-exposed, and because an unstructured 
region of approximately 12 residues surrounding the cleavage site is necessary for the 
proteolytic enzyme to gain access to the site88,89, we apply a step-wise, decreasingly repulsive 
potential to the two residues on either side of each cleavage site, such that the repulsive 
interaction of the residue with each residue in the system has energy:    
 Er = E0e
− i− j /2
j:i− j <3
∑
i∈cuts
∑
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Figure 10. Schematic diagram for structural modeling of meta-stable protein oligomers. 
For each identified cleavage site, we thus generate 5n pairwise constraints, where n is the total 
number of residues in the system. All Gō and experimental constraint potentials are additive. 
Thus, the combined potential function is: 
E = − Δij •δijE0i< j∑ +λ δij ((Er ( j)) / 2)i< j∑ , 
Where Δij is the native contact matrix of the conformation, δij is the contact matrix of the current 
conformation, and λ is a scaling parameter discussed in the next section. Our algorithm 
produces competition between the native SOD1 structure and the information inferred from 
limited proteolysis experiments about the SOD1 trimeric structure. In addition, the energy 
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function rewards native interactions with some energy, E0, which will apply to both inter- and 
intra-chain interactions, including the possibility of domain-swapping interactions, since regions 
that tend to interact in the native structure will also favorably interact between misfolded 
monomers. Thus, native interface interactions and domain-swapping interactions comprise the 
attractive force between monomers that will, after including the perturbation of repulsion 
obtained from experimental data, result in the trimeric interfaces. 
Parameterization of bias potential.  In order to scale the two terms of our bias potential, 
we test the effect of various λ from 0.0 to 30 at intervals of 0.3 (from 0.0 to 3.0) or 3 (from 3 to 
30) in coarse-grained62,66 replica exchange DMD simulations of apo-SOD1 monomer, which 
features a well-defined folding pathway. We utilize a four-bead protein model, which represents 
each residue using four beads: one for the carbon, alpha-carbon, nitrogen, and the side-chain 
beta-carbon62,66. Glycine, which has no side chain, is represented using only three beads. 
Because they contain fewer particles for the same size of system, and hence fewer necessary 
calculations are needed to perform simulations, coarse-grained protein models are useful tools 
for increasing the speed of simulation production. The four-bead protein model is an 
intermediate coarse-grained model that features the speed advantage of coarse-graining while 
still allowing for accurate modeling of backbone dihedrals and hydrogen bond formation. The 
four-bead protein model also allows for simplicity in applying constraints, as attraction and 
repulsion interactions can be applied directly to the beta-carbon bead (or alpha-carbon bead for 
glycine). We utilize the DMD simulation engine to evolve our coarse-grained system over time 
according to our bias potential. The DMD engine is a variation on traditional molecular 
dynamics engines, where pairwise interactions between particles are modeled using step 
functions in place of continuous potentials. The DMD algorithm is discussed in detail 
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elsewhere61,62. In the replica exchange (REX) method, we perform simulations of multiple, 
identical copies of the system at a range of temperatures in parallel. The REX method is 
explained in detail elsewhere67,68. Briefly, at given time intervals, replicas of neighboring 
temperatures exchange temperature values according to a Metropolis-based stochastic algorithm. 
This exchange allows the system to overcome energetic barriers at higher temperatures, while 
retaining a realistic free energy profile at lower temperatures. We set the temperature exchange 
interval at 1000 DMD time steps. The temperature range of the replicas covers the entire 
transition profile of the given system, such that the system is disordered at the highest 
temperatures and stable and ordered at the lowest temperatures. In order to find the ideal range 
and separation between replicas, first we perform a wide range of single-temperature 
simulations and construct a Temperature vs. Energy plot, from which the transition profile of 
the system is apparent. We then choose temperatures for replicas that cover this range, and fine-
tune such that the successful exchange rate between adjoining replicas is between 0.2 and 0.7. 
We utilize 19 replicas in our coarse-grained simulations of the SOD1 apo-monomer system: 
0.450, 0.475, 0.498, 0.516, 0.534, 0.554, 0.574, 0.595, 0.616, 0.637, 0.658, 0.678, 0.699, 0.720, 
0.740, 0.759, 0.779, 0.805, 0.855 kcal/(mol!kB). It is important to note that, due to the manner 
in which energy is calculated, temperatures between coarse-grained and all-atom systems are 
not comparable. We perform simulations for 106 time steps (approximately 50 ns) for each 
replica. 
We examine the resulting energetic profiles and folding trajectories and calculate the 
specific heat and radius of gyration as a function of temperature for each value of λ. We select 
values of λ that produce distinct folding intermediates with clear energetic transitions. The 
presence of folding intermediates denotes competition between Gō and experimental energy 
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terms, demonstrating adequate scaling between the two terms in the energy function, while 
distinct folding transitions are indicative of a realistic protein folding pathway. At λ=0 (Gō 
potential only), we find a single, sharp folding transition with no intermediates (Figure 11), as 
expected from experimental findings79. At λ ≥ 1.3, we cannot resolve individual thermodynamic 
 
Figure 11. Folding of SOD1 monomer with λ=0. SOD1 monomer folding features two distinct states with no 
folding intermediates. Transitions in energy and radius of gyration are sharp and well-defined. Trajectories from 
T=0.80 and T=0.85 are located at the transition, and exhibit flipping between folded and unfolded structures. 
transitions, a behavior that indicates non-cooperative folding to an extent that is unrealistic for 
proteins. We find that that λ values 0.66 ≤ λ ≤ 0.99 fit our criteria for selection (Figure 12), and 
that values in this range produce nearly identical final structures in our test apo-monomer 
system (Figure 13). In the trimeric system, the increase in the number of Gō constraints over the 
monomeric system is greater than the increase in the number of experimental constraints, so we 
therefore select the upper range of the scaling factor, λ = 0.99, for use in modeling of trimeric  
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Figure 12. Folding of SOD1 monomer with λ=0.66. SOD1 monomer folding features distinct intermediate states 
with mid-range λ. Transitions in energy and radius of gyration remain well-defined. Trajectories from T=0.70, 
T=0.75, and T=0.80 are located at the transition, and exhibit flipping between states. 
SOD1. 
Coarse-grained simulation. In order to obtain initial trimeric SOD1 structures that agree 
with experimental data, we utilize discrete molecular dynamics61,62 replica exchange67,68 
simulations (DMD REX). We apply our bias potential to a four-bead model (discussed above) 
of three natively-folded SOD1 apo-monomers placed in proximity to each other but not initially 
bound. For scaling parameter λ = 0.99 (discussed above), we utilize 27 replicas, with 
temperatures of 0.435, 0.445, 0.455, 0.462, 0.470, 0.480, 0.490, 0.503, 0.513, 0.523, 0.538,  
0.552, 0.566, 0.581, 0.595, 0.610, 0.625, 0.639, 0.654, 0.674, 0.694, 0.713, 0.733, 0.753, 0.768, 
0.788, and 0.815 kcal/(mol!kB). We perform simulations for 106 time steps for each replica 
(Figure 10). 
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In order to demonstrate agreement with limited proteolysis results, each proteolytic cut 
site residue should make as few contacts with other residues as possible, since its ability to be 
cleaved by proteolytic enzymes denotes its solvent accessibility and lack of participation in 
secondary structure interactions. We therefore evaluate the experimental agreement of each 
structural snapshot from simulation by calculating the average number of contacts made by each 
proteolytic cut site residue (Nc). However, while the proteolytic cleavage sites should 
demonstrate a minimum of structural interaction, size exclusion chromatography results (Redler 
et al., submitted) indicate that the structure should be a compact, associated trimer. We therefore 
utilize a combination of proteolytic cut site contacts and trimer radius of gyration (Rg), a 
measure of the size of the complex, to select a pool of candidate structures from all coarse-
grained REX simulation trajectories. When we examine these two criteria together, we find 
groups of structures featuring similar Nc grouped together, with varying Rg. We select those 
Figure 13. Perturbed SOD1 monomer features nearly identical structures at λ=0.66 and λ=0.99. Views of 
the perturbed SOD1 monomer at λ=0.66 (pink, left) and λ=0.99 (blue, left) as compared with the native dimer 
(grey, left). All three structures align in all areas except for beta-strands 1-3, which are unstructured in the 
perturbed monomers (right). 
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structures with Nc < 1.5 and Rg < 30 Å (approximately three times the Rg of native monomer) 
(Figure 14). We cluster this pool of candidate structures by pairwise root mean square deviation 
(RMSD), and select the centroid of the largest cluster for further simulation and structural 
refinement (Figure 10). 
 
Figure 14. SOD1 trimer structures group by average number of contacts (Nc) and radius of gyration (Rg). 
All-atom simulation. We reconstruct the four-bead centroid structure that we obtain from 
the DMD REX simulations described above to an all-atom model according to the Medusa force 
field62,63. In the all-atom protein model62,63, all heavy atoms as well as polar hydrogens are 
explicitly represented. In all-atom DMD simulations, bonded interactions are described by 
infinite square well constraints on bond lengths, angles, and dihedrals, making bonded 
interactions effectively permanent. Non-bonded interactions are discretized from the Medusa 
force field64, which includes van der Waals interactions (Lennard-Jones potential), solvation 
 38 
(Lazaridis-Karplus model65), and explicit hydrogen bonding (reaction algorithm66). We perform 
structural minimization using Chiron92 in order to remove clashes introduced by reconstruction. 
Chiron uses short, high-temperature, high heat exchange simulations to resolve clashes while 
minimally affecting the backbone of the protein structure. We then conduct low-temperature 
simulations to accommodate the obtained trimer structure to the all-atom regime. We perform 
low-temperature (below the melting transition) all-atom REX simulations using 26 replicas with 
temperatures of 0.350, 0.360, 0.370, 0.380, 0.390, 0.400, 0.410, 0.420, 0.430, 0.440, 0.450, 
0.460, 0.470, 0.480, 0.490, 0.500, 0.510, 0.520, 0.530, 0.540, 0.550 0.560, 0.570, 0.580, 0.590, 
and 0.600 kcal/(mol!kB). We select the ideal number of replicas and spread of replica 
temperatures such that exchange of replicas occurs with an acceptance rate between 0.2 and 0.7, 
with exchange attempted every 1000 time steps. We perform simulations for 106 time steps for 
each replica. We isolate the lowest-energy structure from all simulation replicas and continue 
simulation of that structure at a temperature of 0.350 kcal/(mol!kB) for an additional 106 time 
steps. Finally, we select the lowest-energy structure from this single-temperature trajectory as 
our final model, and verify the quality of the model using Gaia93 (Figure 10), which compares 
various structural parameters with those of high-resolution crystal structures from the Protein 
Data Bank. 
With the use of a high-performance computing cluster (Dell C6100 servers with 12-core, 
2.93 GHz Intel processors, 12M L3 cache, and 48 GB memory), the computational protocol 
from input of experimental constraints to output of a structural model can be completed for 
SOD1 in two weeks of real time, with computational time totaling approximately 12,000 
computational hours. Our SOD1 trimer model, discussed below, is to our knowledge the first-
ever structure of a disease-relevant, meta-stable protein aggregate.  
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3.2 SOD1 trimer constraints applied to monomer demonstrate rearrangement of monomer 
structure inside trimer 
 When we map the results of the limited proteolysis experiments to the native, dimeric 
SOD1 structure (Figure 15), we find that if SOD1 were to keep its native tertiary structure and 
interface many of these sites would be in secondary structure elements or even in the dimeric 
interface. Since enzyme cleavage is impossible under those conditions, we conclude that the 
SOD1 monomer inside the trimeric structure features significant rearrangement from the native 
structure. 
 In order to determine the extent of this rearrangement, as well as to parameterize our 
experimentally-derived force field and determine the proper temperature range for the monomer 
folding/unfolding transition in that force field (Section 3.1), we apply our method described in 
the previous section to the single chain of the SOD1 monomer. The structure that we obtain 
features high agreement with experimental constraints, in that those residues known to be 
cleavage sites undergo a minimum of interactions with other residues in the protein, and are 
solvent-exposed and not members of secondary structural elements (Figure 16). We further note 
that, while some elements of the structure seem to be similarly arranged as in the native 
structure (mainly that area directly opposite where the native dimer interface would be, which 
natively contains the metal ions), the beta-strands of the N-terminal region have flipped out 
from the beta-barrel and unfolded to accommodate the cluster of cleavage sites concentrated in 
this area (Figure 16). Interestingly, the N-terminal region that we see here as non-natively 
unfolded is a similar region as that identified by Chan and colleagues in their assessment of the 
aggregation surface in SOD1 amyloid fibrils94. These two findings taken together suggest the 
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Figure 15. Limited proteolysis cleavage sites mapped to SOD1 native dimer structure. (Top) Limited 
proteolysis cleavage sites along the linear SOD1 sequence. Enzyme, cleavage site residue, and pH of the 
proteolytic reaction are indicated. Diagram courtesy of Lanette Fee. (Bottom) Cleavage sites highlighted in hot 
pink. We note that most cleavage sites are located in regions natively engaged in secondary structure interactions or 
in the dimer interface, leading us to conclude that SOD1 undergoes significant tertiary and quaternary 
rearrangement during trimer formation. 
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possibility that the SOD1 trimer is a meta-stable intermediate on the pathway to formation of 
these fibrils. Alternatively, the two species could belong to different pathways competing for the 
same aggregation interface surfaces on SOD1 misfolded monomers.  
 
Figure 16. Location of limited proteolysis cleavage sites mapped to perturbed SOD1 monomer structure. 
Cleavage sites are highlighted in hot pink, with a sphere for each alpha-carbon for clarity. 
 
3.3 SOD1 trimer is a degenerate species with defined interfaces 
 Having calibrated our hybrid structure determination method using the well-defined 
SOD1 monomer system and obtained potentially interesting preliminary results, we apply our 
method to obtain a structure of the SOD1 trimer. To account for the association of the three 
monomers, we expand the contribution of native interactions to include the possibility of 
domain swapping interactions. For example, if within one monomer, residue 20 undergoes a 
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native interaction with residue 83, then the interaction 20-83 would be rewarded, as well as all 
pairwise interactions between the two sets [20, 173, 326] and [83, 236, 389] (e.g., 20-236, 326-
83, 173-389). Dimer interface interactions are also incorporated to treat all monomers as 
possible partners; for example, dimer interface interactions between monomers 1 and 2, 1 and 3, 
and 2 and 3 would all be rewarded. We note that these interactions cannot possibly all be 
fulfilled in the same structure; we design these interactions specifically to induce competition 
for favorable interactions, as would occur in the real-world system. 
 After applying our biased force field in coarse-grained replica exchange simulations, we 
obtain a representative SOD1 trimer structure by clustering all structures that fit the criteria of 
being compact, associated trimers featuring the best agreement with experimental results (low 
Rg and low Nc, the average number of contacts of cleavage site residues, Section 3.1). We then 
equilibrate the representative structure in a physical force field for two rounds of simulation: 
low-temperature replica exchange followed by low-temperature single-temperature equilibration 
(Section 3.1). We select the lowest energy structure from the replica exchange simulations to 
continue the single-temperature equilibration, and the lowest energy structure from the single-
temperature equilibration as our final structural model of SOD1 trimer (Figure 17). We note that 
two of the three monomers retain some similarity to the natively-folded SOD1 monomer 
(RMSD from native structure: 11.9 Å and 12.1 Å), with the native beta-barrel opening and 
rearranging while retaining some native beta-strand pairings. The third monomer, with an 
RMSD of 19.3 Å from the native monomeric structure, has completely unfolded and rearranged, 
and is mostly unstructured (Figure 17). The SOD1 trimer model features an overall potential 
energy of -1717 kcal/mol, and a free energy (ΔG) of -538 kcal/mol, as measured by the Medusa 
force field64. These calculated energies reveal sufficient stability to be expected for a meta- 
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Figure 17. Structural model of SOD1 trimer. Individual monomers colored green, cyan, and magenta. 
Monomers 1 and 3 (green and magenta, respectively) retain native secondary structure with rearranged tertiary 
structure. 
stable species of the size of SOD1 trimer. We further apply quality control filters to our model, 
in order to assure that our model conforms to realistic physical properties of proteins93. We find 
that fulfillment of hydrogen bonding, presence of intra-structural voids, and proportion of 
solvent-exposed surface area are within the distributions expected for real proteins (Figure 18). 
The increased size and number of interactions in the SOD1 trimer as compared to the 
monomer introduce an exponentially higher degree of complexity to the trimer system. As a 
result of this added complexity, the most important consideration is assuring proper sampling in 
the modeling of monomer-monomer association interfaces, in that we are not introducing a 
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Figure 18. Evaluation of SOD1 trimer model structural quality. Using the Gaia tool93, we evaluate the 
structural integrity of the SOD1 trimer model: percentage of satisfied hydrogen bonds in the core and on the 
surface, exposed surface area as compared to protein size, and total volume of any intra-structural voids as 
compared to protein size. All parameters of the trimer structure (red vertical lines) are compared to the distribution 
of these quantities for high-quality structures in the PDB (black curves). 
possible bias to the system by our initial placement of the three monomers in relation to one 
another. To address this concern, we create ten identical systems to which we apply our method 
in parallel, with the only difference between the systems being random rotation of initial 
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position of the three monomers in relation to each other. Upon applying our method to each 
system, we obtain ten different models featuring diverse tertiary structures of the individual 
monomers (Figure 19). Such diversity in models from identical systems using identical force 
fields, only varying the initial position, could indicate insufficient sampling during simulation. 
However, considering the extent of sampling performed and the meta-stable nature of the 
system that we are modeling, we believe it more likely that the SOD1 trimer features a 
degenerate structure. In other words, we conclude from this data that the population of 
structures that makes up SOD1 trimer is highly heterogeneous. As a consequence, we may 
obtain an ensemble of possible structures, but a single structure representing SOD1 trimer is 
necessarily incomplete. The models that we obtain from the ten independent applications of our 
method fall into three evenly-represented categories: (1) three discrete, associated monomers 
(three structures); (2) two domain-swapped monomers and one discrete, associated monomer 
(four structures); (3) three domain-swapped monomers (three structures). In accordance with the 
hypothesis that the SOD1 trimer population is highly structurally heterogeneous, all models 
have differences in potential energy of less than 3% as calculated in the Medusa physical force 
 
 
Figure 19. Replicate SOD1 trimer models feature significant variation in tertiary and quaternary structure. 
Models vary in the degree of domain swapping, as well as amount of native tertiary structure maintained in each 
monomer. 
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field, and can be considered essentially equivalent. This finding supports the conclusion that the 
heterogeneity of model structures is due to the meta-stable nature of the SOD1 trimer and the 
competition between various states with similar energy. 
Although we cannot obtain a single, definitive overall structure of the SOD1 trimer on 
which to base our further studies, in order to accomplish our ultimate goal of inhibiting toxic 
oligomer formation we need only to target the non-native aggregation interfaces. Therefore, the 
core of the SOD1 trimer structure is the only relevant information that we need in order to fulfill 
our purposes. On examination of our obtained models, we find that while the tertiary structure 
and to some extent quaternary structure of the SOD1 trimer is highly diverse, the identity of 
residues in the interface between each structure is constant (Figure 20). Despite the apparent 
differences in regions exposed to the surface, which may be highly unstructured and we 
therefore expect significant variation, the consistency with which we identify residues that 
participate in non-native aggregation interfaces confers a high level of certainty that the 
identified residues participate in core interactions involved in SOD1 trimer association. These 
residues and the non-native aggregation interfaces that they form are of key interest for our goal 
of affecting the formation of SOD1 trimer. We directly target these non-native trimer interfaces 
in order to stabilize or destabilize SOD1 trimer formation. 
In order to affect SOD1 trimer formation, we must first understand the character of the 
non-native trimeric interfaces and how we may alter them to inhibit or promote the association 
of monomers into trimer. Because SOD1 trimer interfaces have essentially the same 
composition between all of the models, for simplicity we direct our in-depth characterization to 
the interfaces in the first model (Figure 17). Because one of the monomers is in a more extended 
state than the other two, interfaces involving this more unstructured monomer are 
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Figure 20. Agreement of SOD1 trimer interface residue identity between models. In a pairwise comparison of 
each SOD1 trimer model with every other model (between 10 models, 45 comparisons in all), we find that the set 
of residues in the trimer interfaces is highly similar: the most similar pair features 94% identity, while the least 
similar features 77% identity. 
larger (2285 and 2182 Å2) and more energetically stable (-184 and -150 kcal/mol) than the 
interface between the two more structured monomers (743 Å2, -38 kcal/mol). The significant 
difference in interface areas implies that the unstructured monomer may be the main contributor 
to trimer formation. 
As discussed above, the identity of residues in the SOD1 trimer interface is highly 
similar among the heterogeneous population of SOD1 trimer structures. Thus, the associating 
core of the potentially toxic SOD1 trimer is constant, despite differences in secondary, tertiary, 
or even quaternary structure. The presence of disease mutations in the SOD1 trimer interfaces 
could shed light on the disease-relevance of SOD1 trimer. We find that for several (11) of the 
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identified trimer interface residues, the residue at that sequence position is contributed to the 
interface by each of the three monomers (Table 5). A mutation at any of these 11 sequence 
positions would thus have a triple effect on trimer formation, since all of the monomers 
contribute this residue to an interface. Interestingly, two of these 11 sequence positions (18%) 
feature disease mutations. Forty-three additional residues are present in the trimer interface as 
contributed from two monomers, mutation of which would have a double effect; 14 (33%) of 
these residues feature disease mutations. Out of the total 61 residues in SOD1 that undergo a 
disease-relevant point mutation, 38 of these residues are contained in the trimer interface (62%) 
(Table 5) (ALSOD database, http://alsod.iop.kcl.ac.uk). While additional experiments are 
needed to definitively link SOD1 trimer to ALS, computational analysis reveals that 34 out of 
the 51 different disease mutations in the trimeric interfaces are stabilizing to the trimer (Table 6), 
reinforcing the hypothesis that SOD1 trimer may be a neurotoxic species in ALS. 
 Similarly as to in the application of the method to SOD1 monomer, we note that one 
interface of the SOD1 trimer comprises nearly all of the residues 1-63 from both participating 
monomers (Table 5), which Chan and colleagues94 found to be the aggregating core of SOD1 
amyloid fibrils. The other two interfaces also contain some of these residues from each 
participating monomer. The similarity between one of the three trimer interfaces and the 
amyloid fibril aggregation interface again points to the possibility that SOD1 trimer could be 
either an intermediate or a competitor to the amyloid aggregation pathway.  
 
3.4 Mutation to proposed trimer interfaces affects formation of SOD1 trimer 
 Just as disease-relevant mutations in the SOD1 trimeric interfaces could act by 
promoting a potentially toxic species, we can use mutagenesis to test whether we correctly  
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Table 5. Residues composing the SOD1 trimer interface. Bolded residues with a double asterix are locations of 
known disease mutations. 
Residue Monomers Residue Monomers Residue Monomers 
1 3 46** 1 103 2 
2 3 47 3 104** 1 
4** 2 48** 2 105** 2 
5 1 49 2 106** 2 
6** 2 51 1 108 3 
7** 1 52 2 109 3 
8** 2 53 2 110 2 
10** 1 56 2 111** 3 
12** 1 57 1 112** 2 
13 1 58 1 114** 2 
16** 2 61 1 115** 1 
17 2 62 2 116 2 
18 2 63 1 117 2 
19** 2 64 1 118** 2 
20** 1 65** 3 119 2 
21** 1 66 3 120 2 
22** 1 67 3 121 3 
23 2 68 3 124** 1 
24 2 69 2 125** 1 
25 2 70 1 127** 1 
27 1 73 2 130 1 
28 2 74 1 131 1 
29 1 75 1 132 1 
30 1 76** 1 133 1 
31 2 77 2 134** 1 
33 2 78 2 135 1 
34 2 79 1 136 2 
35 1 93** 1 138 2 
37** 1 95** 2 141** 2 
38** 1 96 1 145** 1 
41** 2 98 1 147** 1 
42 1 99 1 148** 2 
44 2 101** 1 150 1 
45** 1 102 2 152 1 
 
 
identify the regions of the SOD1 monomer that associate into the trimeric form. We perturb our 
proposed interfaces by introducing mutations at those residues predicted to reside in the trimeric 
interfaces, and then observe the effect of those mutations on SOD1 trimer formation and 
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Table 6. Effect of ALS disease mutations on SOD1 trimer, dimer, and monomer stability. All energy 
differences greater than 20 kcal/mol are exceedingly (de)stabilized such that all above this point cannot be 
distinguished as more or less (de)stabilizing, hence any difference of 20 kcal/mol or larger is simply labeled “(-)20 
kcal/mol.” 
Resi AA Trimer 
ΔΔGmut 
(kcal/mol) 
Dimer 
ΔΔGmut 
(kcal/mol) 
Monomer 
ΔΔGmut 
(kcal/mol) 
Resi AA Monomer 
ΔΔGmut 
(kcal/mol) 
Dimer 
ΔΔGmut 
(kcal/mol) 
Trimer 
ΔΔGmut 
(kcal/mol) 
4 S -9.51 5.72 -2.25 93 S 2.80 20 9.94 
4 T -12.99 9.07 -2.74 93 V 20 14.99 15.00 
4 V -4.84 8.65 0.62 95 T -15.23 16.53 -0.28 
7 E -3.71 12.87 -4.10 101 G -0.75 4.96 -1.86 
8 Q -1.05 12.07 1.65 101 H 0.31 9.36 0.14 
8 V -6.48 1.13 4.98 101 N -8.33 -1.37 -1.11 
10 R 15.74 20 2.72 101 Y 0.92 14.85 -1.06 
10 V 16.08 20 2.05 104 F 19.48 20 6.93 
12 R -2.96 20 2.05 105 L -14.35 -7.76 -6.38 
16 S -5.17 19.26 6.76 106 F 13.18 20 2.70 
19 S -7.77 2.32 -2.96 106 V 7.35 4.34 -2.92 
21 K -10.52 4.36 1.79 112 M -3.70 -7.88 -1.98 
22 L -11.60 4.62 -6.26 112 T -4.58 6.17 2.82 
37 R -7.10 7.43 20 114 A -10.81 11.70 -1.37 
38 V -2.49 -0.41 6.44 115 G -3.48 -0.425 0.439 
41 D 2.05 0.09 -3.87 118 L 2.85 8.34 -4.00 
41 S -1.33 1.25 -1.10 124 G -6.60 7.75 -4.15 
46 R -1.71 7.85 -1.62 125 H -6.84 5.79 -3.27 
48 Q -5.29 6.81 0.66 127 R -2.29 20 20 
48 R -2.54 5.67 -5.05 134 N -8.50 3.17 6.11 
65 S 3.24 1.19 -0.81 141 E 20 7.28 1.21 
76 V -6.56 12.79 2.92 145 T -8.66 5.19 4.39 
76 Y -6.81 2.92 -1.19 147 R 20 20 20 
93 A -3.80 12.80 0.70 148 G 1.54 13.44 -5.31 
93 D 20 20 -0.72 148 I -11.13 -2.32 2.88 
93 R 20 20 -0.08      
 
aggregation. We guide our choice of mutations using Eris59,60, a computational tool that 
estimates the change in stability of the protein upon mutation (ΔΔGmut). Using our SOD1 trimer 
model, we perform computational mutagenesis of every residue residing in an interface between 
monomer chains. We designate a residue as residing in an interface if any atom of that residue is 
within 4.5 Å of any atom of a residue belonging to a different monomer chain. We perform 
computational mutagenesis of each interface residue to every possible amino acid, with the 
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exception of cysteine due to complexity in its interactions. Following this exhaustive test of all 
possible mutations at each interface residue, we select for experimental study those mutations 
that have a significant (|ΔΔGmut| > 3 kcal/mol) effect on the stability of SOD1 trimer, but a 
negligible (|ΔΔGmut| < 1 kcal/mol) effect on native SOD1 dimer and monomer (Table 7). The 
reason for these criteria is that we want to isolate in experiments, as much as possible, only the 
direct effect of the mutation on the trimer, avoiding the possibility of increased or decreased 
trimer population as a secondary effect of the mutation stabilizing or destabilizing SOD1 dimer 
or monomer. In this case, we can be sure that any effect that we observe on the formation of 
SOD1 trimer or further aggregation steps is due to perturbation of the proposed trimer interfaces. 
Table 7. Effect of chosen mutations on stability of SOD1 trimer, dimer, and monomer. All energy differences 
greater than 20 kcal/mol are exceedingly (de)stabilized such that all above this point cannot be distinguished as 
more or less (de)stabilizing, hence any difference of 20 kcal/mol or larger is simply labeled “(-)20 kcal/mol.” 
 Original 
AA 
Residue Mutation 
AA 
Trimer 
ΔΔGmut 
(kcal/mol) 
Dimer 
ΔΔGmut 
(kcal/mol) 
Monomer 
ΔΔGmut 
(kcal/mol) 
Stabilizing 
H 46 Q -16.25 0.23 -0.16 
D 124 Q -12.83 0.66 -0.54 
K 136 H -11.44 -0.55 0.17 
F 20 L -11.05 0.02 0.42 
P 74 G -10.85 0.37 -0.25 
E 21 Q -10.68 0.77 -0.49 
Destabilizing 
P 62 Y 20 -0.69 -0.49 
G 147 P 20 0.86 0.00 
G 108 H 14.89 0.74 -0.21 
I 99 H 8.33 -0.23 0.48 
D 101 I 7.20 0.92 -0.68 
N 53 I 6.05 -0.92 -0.73 
N 65 V 3.57 -0.64 -0.09 
 
 We observe the aggregation of our designed mutant SOD1 in aggregation time course 
experiments with purified mutant SOD1 protein using size exclusion chromatography (SEC). 
SEC separates species over a sizing column by molecular radius, with larger species eluting 
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sooner (at lower elution volume) than smaller species. Because the separation of species is 
performed by molecular radius and not by molecular mass, two dimeric species could elute in 
different places if one is in a more extended conformation than another, or, conversely, a dimer 
and a trimer could elute together if the dimer is extended and the trimer is compact. For this 
reason, determining the stoichiometry of meta-stable or partially unfolded species is difficult 
with SEC. However, a collaboration with Yuri Lyubchenko and his research group at the 
University of Nebraska Medical Center has yielded evidence using high-speed atomic force 
microscopy (HS-AFM) that the species that we find to elute at what calculates to approximately 
trimeric radius is indeed a SOD1 trimer (Figure 21). 
 
Figure 21. High-speed atomic force microscopy visualization of SOD1 trimer. SOD1 trimer comprises three 
distinctly delineated monomers, and is stable over time at pH 3.5. Scale bar is 5 nm. Image credit: Yuliang Zhang, 
Zhengjian Lv, and Yuri L. Lyubchenko. 
 To obtain SOD1 trimer for our experiments, we perform cloning, expression, and 
purification of human recombinant SOD1 as described elsewhere49,50,95 (Redler et al., 
submitted). We determine the concentration of purified SOD1 species by measuring the 
absorbance at 280 nm with an extinction coefficient of 10800 M-1cm-1. We dilute the purified 
mutant and wild type SOD1 to 30 µM, and incubate at 37 °C at time zero (t = 0). At designated 
HSAFM&imaging&of&30&nM&SOD1&at&pH&3.5&
Bar&size&5&nm&
9&The&images&are&from&ph3.5_106_765B999.gif.&The&original&area&is&50*50&nm&
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time points (t = 0, 2, 4, 8, and 24 hours), we withdraw and filter (filter size: 0.22 µm) aliquots of 
each sample, and separate SOD1 species by SEC at 4 °C using an ÄKTA Purifier with 
Superdex 200 10/300 GL column (GE Healthcare) equilibrated in 50 mM sodium acetate, 150 
mM NaCl, 10 mM EDTA (pH 3.5). 
Upon observing the aggregation profiles of our designed mutants, we find that those 
mutations designed to destabilize the SOD1 trimer are in the majority of cases successful, with 
less trimer forming than in the wild type system or the trimer species rapidly disappearing in 
favor of larger aggregates. Upon destabilization of the trimer interfaces, we observe one of two 
outcomes: (1) inhibited trimer formation with resulting increased populations of SOD1 
monomer and dimer species, or (2) inhibited trimer formation with resulting increase in large 
aggregates. Exhibiting the first outcome, in three cases (P62Y, G108H, N65V) we see the 
formation of what we believe to be a non-native extended dimer species (Figure 22). We 
hypothesize that this dimer is highly unstructured, although associated, because of the 
difference in elution volume from the native dimer (~15.8-16 mL, as compared to ~16.5 mL for 
the native dimer). Alternatively, this species could be a very compact SOD1 trimer, but the 
gradual change in elution volume of the species over time from >16 mL to <16 mL in these 
mutants suggests that an extended, partially unfolded SOD1 dimer is the more likely scenario. 
As in wild type SOD1, we do not observe the formation of large aggregates in these mutants, 
with the exception of a very small peak in the void volume of N65V-SOD1. In G108H-SOD1, 
we note that the dimeric form of the protein is especially stable, even more stable than the wild 
type dimer, as the dimer is the dominant species at all time points. Interestingly, the population 
of monomeric species remains exceedingly low at all time points in this mutant. Because the 
presence of monomer is required to form SOD1 trimer, the growth of the left-most peak without  
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Figure 22. Mutations destabilizing to SOD1 trimer result in increased dimer and monomer populations. SEC 
of 30 µM SOD1 incubated for given time at 37°C (t = 0 is time of dilution). SOD1 monomer elutes at 
approximately 17 mL, dimer at approximately 16 mL, and trimer at approximately 15 mL. Void volume is 
approximately 8 mL. Peaks eluting at greater volume than monomer are not protein. 
a compensating change in monomer population could suggest that this peak actually represents 
an even further extended dimeric conformation, rather than a trimer. N65V-SOD1 and P62Y-
SOD1 both exist primarily as monomers at the initial time point, and then form dimer and trimer 
concurrently with a compensating decrease in monomer population. While dimer is the 
dominant species in N65V-SOD1 from the beginning, dimer and trimer are formed in 
approximately equal amounts in P62Y-SOD1. However, in comparison to wild type, in which 
the trimeric species dominates by the 24-hour time point, P62Y-SOD1 exhibits inhibition of 
trimer formation. 
In the second possible outcome of trimer-destabilizing mutations, we observe the 
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immediate formation of large aggregates in D101I-, G147P-, and N53I-SOD1 (Figure 23). In 
these high-aggregation mutants, some SOD1 trimer is formed in the early hours of the time 
course, quickly followed by the appearance of large, void volume aggregates. Because these 
aggregates elute immediately in the void volume of the column, their size cannot be estimated 
using SEC, but we can put a maximum limit of 220 nm on their diameter due to the size of the 
centrifugal filter that we use before injection into the FPLC. We find that the G147P mutation 
induces exceptionally fast aggregation. At t = 2 hours, nearly all injected protein can be found in 
the void volume, and by t = 8 hours we observe a sharp decrease of the amount of protein 
present in the experiment, due to loss of most of the protein during the filtering step. The size of 
 
Figure 23. Mutations destabilizing to SOD1 trimer result in formation of large aggregates. SEC of 30 µM 
SOD1 incubated for given time at 37°C (t = 0 is time of dilution). SOD1 monomer elutes at approximately 17 mL, 
dimer at approximately 16 mL, and trimer at approximately 15 mL. Void volume is approximately 8 mL. We note 
that the aggregation profile of N53I is slightly shifted to the left, with a void volume of approximately 7.5 mL. 
Peaks eluting at greater volume than monomer are not protein. 
 56 
the filter (220 nm) indicates the large size of the resulting protein aggregates after only 8 hours. 
In D101I- and N53I-SOD1, we observe an increase in void volume aggregates, but no loss to 
the pre-injection filtering step. The D101I mutation results in a large spread of diverse large 
aggregates, as evidenced by a single, broad peak ending abruptly at the void volume as early as 
the 2-hour time point. Interestingly, D101I-SOD1 seems to aggregate nearly entirely directly 
from monomer to large aggregates, with initial small populations of dimer and trimer that 
disappear over 24 hours. In N53I-SOD1, we observe an initially large dimer population directly 
form large aggregate species with no observable intermediates (we note that the aggregation 
time course for this experiment is shifted 0.5 mL to the left). In all three of these trimer-
destabilizing mutations, no SOD1 trimer is formed, and instead the protein forms large void 
volume aggregates. We can interpret this result to indicate that large, insoluble aggregates such 
as fibrils lie on a different, competing pathway from the formation of small, soluble aggregates, 
especially given that no small intermediates appear to form in any of the destabilizing mutants 
that form large aggregates. In the mutations resulting in the first outcome, in which only 
monomer and dimer species are observed (with decreased, if any, amounts of trimer), it is 
possible that the same mutations responsible for destabilizing trimer formation also inhibit the 
formation of larger aggregates.  
In one predicted trimer-destabilizing mutant, I99H, we find the opposite behavior from 
that which we predict: SOD1 trimer is present as the dominant species immediately from t = 0, 
and the distribution of species remains stable through the 24-hour time point (Figure 24). 
Further analysis of the resulting species is needed to ascertain the reason for the discrepancy 
between prediction and experiment, but we propose two possibilities for this difference: (1) 
because of the nature of the force field, computational predictions are carried out in “neutral”  
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Figure 24. Predicted trimer-destabilizing mutant potentially forms super-stable SOD1 trimer. SEC of 30 µM 
SOD1 incubated for given time at 37°C (t = 0 is time of dilution). SOD1 monomer elutes at approximately 17 mL, 
dimer at approximately 16 mL, and trimer at approximately 15 mL. Void volume is approximately 8 mL. Peaks 
eluting at greater volume than monomer are not protein. 
conditions of implicit solvent, while we conduct experiments at pH 3.5. Because the mutation is 
performed to a histidine residue, which features a pKa of 6.0, we cannot discount the possibility 
that the difference in the protonation of histidine between computation and experiment changes 
our outcome. Alternatively, (2) what we assume is a SOD1 trimer could in fact be a non-native, 
extended dimer species, in which case there is no discrepancy between prediction and 
observation. The second hypothesis is supported by the gradual leftward movement of the peak, 
which we have observed in other mutants that feature the extended dimer population (Figure 22, 
Figure 26, Figure 27). 
 The design of stabilizing mutations to a meta-stable aggregation intermediate is much 
more complicated than the design of destabilizing mutations, first because of the documented 
difficulty of favorable mutations in protein design, but perhaps more troubling because of the 
unknown nature of the aggregation pathway. In attempting to stabilize one transient species, we 
may unknowingly stabilize, destabilize, or even create another transient species. While we can 
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account for the stabilization or destabilization of known structures such as the native SOD1 
dimer and monomer, aggregation is a complex process and we cannot account for other meta-
stable species that may be perturbed during our mutation of trimer interface residues, and the 
effect that this may have on whether or not we see the effects of the trimer being stabilized. 
Despite these known difficulties with observing an increase in a meta-stable population upon 
stabilization, we do observe the predicted behavior in some of our predicted stabilizing 
mutations. The most promising example of stabilized SOD1 trimer occurs in the F20L mutant; 
at t = 0, monomer, dimer, and trimer species are all present, but as time progresses the trimer 
species quickly dominates and appears stable, with no larger aggregates forming (Figure 25). 
The F20L mutation demonstrates a clear stabilization of the SOD1 trimer species. 
 
Figure 25. Mutation stabilizing to SOD1 trimer promotes dominant and stable trimer. SEC of 30 µM SOD1 
incubated for given time at 37°C (t = 0 is time of dilution). SOD1 monomer elutes at approximately 17 mL, dimer 
at approximately 16 mL, and trimer at approximately 15 mL. Void volume is approximately 8 mL. Peaks eluting at 
greater volume than monomer are not protein. 
In three additional mutants predicted to be stabilizing to SOD1 trimer, D124Q-, P74G-, 
and E21Q-SOD1, we see formation of trimer that is overcome by the non-native extended dimer 
species (Figure 26), which we could not predict computationally. In two of these species, P74G 
and E21Q, trimer initially forms in amounts comparable to the dimeric species, but toward later  
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Figure 26. Trimer-stabilizing mutations stabilize additional non-native SOD1 species. SEC of 30 µM SOD1 
incubated for given time at 37°C (t = 0 is time of dilution). SOD1 monomer elutes at approximately 17 mL, dimer 
at approximately 16 mL, and trimer at approximately 15 mL. Void volume is approximately 8 mL. Peaks eluting at 
greater volume than monomer are not protein. 
time points we see the appearance of large aggregates in the void volume as the population of 
SOD1 trimer decreases. Contrary to the trimer-destabilizing mutations discussed above, this 
aggregation behavior suggests the possibility that the trimer is the precursor for a larger 
aggregate species, whose stability is also increased by these mutations. The aggregation 
pathway could then be accelerated through the trimer to these larger species. This scenario 
could also be the case for the mutant K136H, for which aggregation profiles could not be 
obtained because the protein aggregates so quickly and to such an extent that all protein remains 
on the 220 nm filter prior to injection in the FPLC, even at t = 0. Due to the readiness with 
which this mutant aggregates, this protein is exceedingly difficult to purify in sufficiently large 
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quantities for performing experiments. Conversely, in another trimer-stabilizing mutant, 
D124Q-SOD1, we do not see formation of larger aggregates; instead, we see a relatively stable 
non-native extended dimer. At t = 24 hours, the extended dimer population seems to increase at 
the expense of the trimeric population, with no larger aggregates formed. The unpredictable 
stabilization of this competing meta-stable species in all three of these predicted trimer-
stabilizing mutants could indicate that the non-native extended dimer and the trimer compete for 
the same aggregation interfaces; in other words, that this extended dimer is not merely a 
partially unfolded native dimer, but has a completely separate interface, one that is similar to the 
trimeric interface. It is then possible that this non-native dimeric species forms from the trimer, 
by the loss of one of its monomers, or is a precursor to the trimer, co-existing in equilibrium. 
Since the monomeric population remains lowered, although it never disappears, it is a 
possibility that the lost monomers later re-associate into non-native dimers. Alternatively, due to 
the low resolution of SEC experiments, what we believe to be an extended dimer could actually 
be a compact trimer, which may explain the consolidating of the first “trimer” peak into the 
second “dimer” peak as time progresses. 
The remaining predicted trimer-stabilizing mutation, H46Q, results in a structural 
landscape dominated almost entirely by the monomeric form, with some dimer and trimer 
forming in later time-points (Figure 27). No large aggregates form in this mutant. We note that 
this mutation, similar to I99H discussed above, involves mutation of a histidine residue, in 
which our computational prediction may result in errors due to differences in protonation state 
between our force field environment and the low-pH conditions present during the experiment. 
The results of our trimer-stabilizing mutations and those of our trimer-destabilizing 
mutations lead to conflicting conclusions about the place of SOD1 trimer on or off pathway to 
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Figure 27. Predicted trimer-promoting mutant remains monomeric. SEC of 30 µM SOD1 incubated for given 
time at 37°C (t = 0 is time of dilution). SOD1 monomer elutes at approximately 17 mL, dimer at approximately 16 
mL, and trimer at approximately 15 mL. Void volume is approximately 8 mL. Peaks eluting at greater volume than 
monomer are not protein. 
large aggregate and fibril formation. On the one hand, when SOD1 trimer is destabilized, we see 
either stabilization of smaller species, in which case we would not observe larger species, or we 
see dramatically increased formation of large void volume aggregates. These results would 
seem to indicate that SOD1 trimer formation is off pathway from large aggregate formation, 
because the two populations compete for monomers in order to form. On the other hand, when 
we observe formation of both SOD1 non-native extended dimer and trimer in trimer-stabilizing 
mutants, we find that in the later time points the trimer population decreases and the large 
aggregate population increases, seemingly at the expense of the trimer, while leaving the 
dimeric species constant or growing with the decrease in monomer. These results suggest that 
the SOD1 trimer is a meta-stable intermediate in the formation of larger aggregate species, and 
is therefore on-pathway to fibril formation. Given these conflicting data, additional experiments 
need to be performed in order to determine the place of SOD1 trimer on the aggregation 
pathway.  
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CHAPTER 4 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 In this work, we have explored strategies to prevent the aggregation of Cu, Zn 
superoxide dismutase (SOD1), implicated in Amyotrophic Lateral Sclerosis (ALS). In both 
genetically inherited and many sporadic cases of ALS, SOD1 is destabilized, dissociating from 
its native homodimeric state to form aggregation-prone monomers. Small, soluble oligomers of 
SOD1 have been implicated in activation of cell death pathways, as well as participating in 
aberrant interactions detrimental to cell function. Currently, no cure or even effective treatment 
exists for ALS or any other neurodegenerative disease, and development of therapeutic 
strategies against the disease is thus an imperative.  
 Here we have determined points on the SOD1 aggregation pathway that can be targeted 
in order to inhibit the formation of possibly toxic small, soluble oligomers: (1) the dissociation 
of dimeric SOD1, the first step on the aggregation pathway, and (2) the oligomerization of the 
resulting SOD1 monomers. We have elucidated the mechanism by which glutathionylation, a 
post-translational modification present in at least 50% of SOD1, promotes dissociation of SOD1 
dimer. We find that the bulky glutathione molecules, which bind SOD1 near the dimer interface, 
cause the monomers to twist in relation to each other in order to avoid steric clashing between 
the modification moieties. This twisting changes the composition and size of the dimer interface, 
breaking important contacts and in some cases forming non-native interactions, which disrupts 
the stabilizing effect of coupling between the interactions of the dimer interface and the those of 
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the beta-barrels. A non-native folding intermediate is stabilized as a result of this decoupling, 
and the energy gap between the associated and dissociated states decreases, increasing the 
population of dissociated SOD1. Utilizing this knowledge as well as the structures that we 
obtain in simulations, we have initiated a drug discovery effort against glutathionylated SOD1, 
screening for compounds that will bind in a pocket joining the two SOD1 monomers in order to 
stabilize the dimeric form and prevent dissociation. We have preliminarily identified two lead 
compounds from a computational screen that appear to bind with very favorable computed 
energy (-50 to -60 kcal/mol) to the identified binding pocket, and have begun experiments to 
test their binding affinities and effects on SOD1 dimer dissociation in vitro.  
In pursuit of the second intervention point to prevent toxicity in ALS, we have 
developed a method to determine the structure and non-native interfaces of meta-stable protein 
oligomers, using a hybrid protocol incorporating experimental data from limited proteolysis into 
a force field to bias discrete molecular dynamics simulations. Using our method, we have 
obtained the first-ever model of a meta-stable protein aggregation intermediate, a significant 
step toward determining the mechanism of toxicity in neurodegenerative disease. From the 
resulting model of SOD1 trimer we have deduced the identity of the non-native aggregation 
surfaces, and predicted mutations that will disrupt or promote the formation of this small, 
soluble oligomer. We have demonstrated the accuracy of our predictions in vitro by performing 
aggregation time course experiments, identifying several mutations that definitively affect the 
formation of this cytotoxic candidate species. We are currently engaging in collaborations to use 
additional experimental tools, high-speed atomic force microscopy and electron microscopy, to 
gain additional insight into the morphology and stoichiometry of the various oligomer and 
aggregate species resulting from our designed mutations. Additional design and testing of 
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mutations to perturb the formation of SOD1 trimer could also reveal whether small soluble 
oligomers lie on-pathway or off-pathway to amyloid aggregation. 
As discussed in Section 3.3, 62% of residues featuring disease-relevant point mutations 
are located in the proposed SOD1 trimer interfaces. Using computational tools, we find that at 
least two-thirds of disease mutations located in the trimer interfaces are overall stabilizing to the 
trimeric interfaces; the effect on the remaining third cannot currently be established, because 
while the effect of a mutation on one trimeric structure may be destabilizing, it could stabilize 
another trimeric form, resulting in a higher fraction of disease mutants stabilizing a trimeric 
form of SOD1. Since we have established that the SOD1 trimer is meta-stable and consists of a 
heterogeneous pool of degenerate structures, this scenario is not only possible, but likely. 
Because mutation can cause conformational changes in proteins, especially when the mutation 
is located in a structurally important region like an interface, mutations could cause an entirely 
different SOD1 trimer to form. Computational testing of each mutation on all possible SOD1 
trimer structures would be prohibitive, and still may not yield an answer to the crucial question: 
do disease mutations cause an increase in the population of trimeric SOD1? Instead, we may 
attack the question from another direction by directly testing the toxicity of SOD1 trimer in 
motor neuron-like cells (NSC-34 cells). We plan to use our trimer-stabilizing mutations, such as 
F20L (Figure 25), to test the cytotoxic effects of large populations of SOD1 trimer, and utilize 
destabilizing mutations for the opposite effect. By repeating experiments with many different 
mutations that affect the formation of SOD1 trimer, and the SOD1 aggregation pathway in 
general, in various ways, we may piece together a picture of which SOD1 aggregates may be 
toxic and which protective. These experiments are already underway in our laboratory. 
Although we rely to some extent on a consistency of aggregation behavior between in vitro and 
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in-cell environments, it may be possible in the future to design an antibody specific to SOD1 
trimer, or other method for ascertaining the presence, specifically, of trimeric SOD1 in cells.  
If elevated populations of SOD1 trimer do increase cell death, blocking the formation of 
SOD1 trimer could be a potential therapeutic strategy for ALS. Because of the high 
concentration of SOD1 in motor neurons (30-100 µM), stoichiometric binding of a drug 
compound is not a viable option to completely abolish trimer formation. An alternative option is 
to stabilize aggregation products further down the aggregation pathway, for which SOD1 trimer 
is a precursor. This strategy has been adopted for amyloid-beta aggregates in Alzheimer’s 
disease, to positive effect38. Yet another strategy would involve identifying and blocking the 
toxic interactions of SOD1 trimer in the cell. Alternatively, we can use the structural knowledge 
that we have gained of the SOD1 trimer for the design of recognition and sequestering strategies.  
In the future, our method for determining structures of meta-stable aggregation 
intermediates can be similarly applied to solve structures of small, soluble oligomers in other 
protein misfolding diseases and test them for toxicity. Knowledge of toxic species in 
neurodegeneration will put us well on the pathway to discovering cures and treatments for these 
age-related, fatal disorders, a must in this new age of increased longevity.  
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